Exact Mass: 417.1413284

Exact Mass Matches: 417.1413284

Found 76 metabolites which its exact mass value is equals to given mass value 417.1413284, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Azelastine Hydrochloride

C22H25Cl2N3O (417.137458)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D018926 - Anti-Allergic Agents Azelastine hydrochloridem, an antihistamine, is a potent and selective histamine 1 (H1) antagonist. Azelastine hydrochloride can be used for the research of allergic rhinitis, asthma, diabetic hyperlipidemic and SARS-CoV-2[1][2][3][4].

N-Acetyl gemifloxacin

1-cyclopropyl-7-[(4E)-3-acetamido-4-(methoxyimino)pyrrolidin-1-yl]-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid

C19H20FN5O5 (417.14484020000003)

N-Acetyl gemifloxacin is a metabolite of gemifloxacin. Gemifloxacin mesylate (trade name Factive, Oscient Pharmaceuticals) is an oral broad-spectrum quinolone antibacterial agent used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia. Oscient Pharmaceuticals has licensed the active ingredient from LG Life Sciences of Korea. (Wikipedia)

3'-Amino-3'-deoxythimidine glucuronide

(2S,3S,4S,5R)-4-{[3-amino-5-(4-hydroxy-5-methyl-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}-3,5,6-trihydroxyoxane-2-carboxylic acid

C16H23N3O10 (417.13833780000004)

3-Amino-3-deoxythimidine glucuronide is a metabolite of zidovudine. Zidovudine or azidothymidine (AZT) (also called ZDV) is a nucleoside analog reverse-transcriptase inhibitor (NRTI), a type of antiretroviral drug used for the successful treatment of HIV/AIDS infectiousness. It is a therapeutic analog of thymidine. AZT is the first U.S. government-approved treatment for HIV therapy, prescribed under the names Retrovir and Retrovis. (Wikipedia)

DTXSID40930256

C20H29Cl2NO4 (417.14735340000004)

3-O-beta-D-glucopyranosylfagomine

(-)-3-O-beta-D-Glucopyranosylfagomine

C21H23NO8 (417.1423598)

TCMDC-135131

C20H18F3N5O2 (417.1412524)

(5S,8S,9R)-8-benzoyl-2-[(1S,2S,3Z)-1,2-dihydroxy-3-hexenyl]-8,9-dihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione|8-O-demethylpseurotin A|pseurotin F2

C21H23NO8 (417.1423598)

N-ethyl-2-pyrrolidinone substituted flavan-3-ols (three hydroxy groups on B-ring)

C21H23NO8 (417.1423598)

C21H23NO8_(2E)-4-({(3S,3aR,4E,7aS)-7-Hydroxy-4-[(2E,4E)-1-hydroxy-2,4-hexadien-1-ylidene]-3,6,7a-trimethyl-2,5-dioxo-2,3,3a,4,5,7a-hexahydro-1-benzofuran-3-yl}amino)-4-oxo-2-butenoic acid

NCGC00380250-01_C21H23NO8_(2E)-4-({(3S,3aR,4E,7aS)-7-Hydroxy-4-[(2E,4E)-1-hydroxy-2,4-hexadien-1-ylidene]-3,6,7a-trimethyl-2,5-dioxo-2,3,3a,4,5,7a-hexahydro-1-benzofuran-3-yl}amino)-4-oxo-2-butenoic acid

C21H23NO8 (417.1423598)

C21H23NO8_(5S,8S,9R)-8-Benzoyl-2-[(1S,2S,3Z)-1,2-dihydroxy-3-hexen-1-yl]-8,9-dihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione

NCGC00381007-01_C21H23NO8_(5S,8S,9R)-8-Benzoyl-2-[(1S,2S,3Z)-1,2-dihydroxy-3-hexen-1-yl]-8,9-dihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione

C21H23NO8 (417.1423598)

MMV024937

C20H18N5O2F3 (417.1412524)

Mefenamic acid Metabolite (b-D-Glucopyranuronic acid, 1-[2-[(2,3-dimethylphenyl)amino]benzoate])

C21H23NO8 (417.1423598)

azaspirium chloride

C22H24ClNO5 (417.13429240000005)

2-Azidoethyl 2,3,4,6-Tetra-O-acetyl-beta-D-glucopyranoside

C16H23N3O10 (417.13833780000004)

Pyroxamine maleate [USAN]

C22H24ClNO5 (417.13429240000005)

3,3-dimethyl-13-(4-nitrophenyl)-4,13-dihydro-2H-indazolo[1,2-b]phthalazine-1,6,11-trione

C23H19N3O5 (417.13246440000006)

1-benzyl-3,4-bis(1H-indol-3-yl)pyrrole-2,5-dione

C27H19N3O2 (417.1477194)

Duloxetine Impurity A

C25H23NO3S (417.1398568000001)

4-(1-Methylethyl)-2-(tributylstannyl)-Thiazole

C18H35NSSn (417.15120600000006)

Mono-POC Methyl Tenofovir (Mixture of DiastereoMers)

C15H24N5O7P (417.1413284)

Chloroquine sulfate

chloroquine sulphate

C18H28ClN3O4S (417.1488958000001)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018501 - Antirheumatic Agents C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Xaliproden hydrochloride

C24H23ClF3N (417.14710240000005)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C26170 - Protective Agent > C1509 - Neuroprotective Agent Xaliproden hydrochloride (SR57746A) is a potent, selective and orally active agonist of 5-HT1A receptor, shows a high affinity for 5-HT1A specific binding sites in the rat hippocampus (IC50=3 nM). Xaliproden hydrochloride is also a selective antagonist of dopamine D2 receptor, has moderate affinity (IC50=0.1-1 μM). Xaliproden hydrochloride exhibits anti-depression and anti-anxiety effects, and it may possess therapeutic potential for the research of neurodegenerative diseases[1][2][3].